 |
 |

Cytokine Secretion by Multiple Sclerosis MonocytesRelationship to Disease Activity
Richard A. Rudick, MD;
Richard M. Ransohoff, MD
Arch Neurol. 1992;49(3):265-270.
Abstract
 |  |
Autoantigen recognition by specific T cells may initiate a tissue-specific immune response in multiple sclerosis (MS), which is a chronic inflammatory demyelinating disorder. During subsequent nonspecific immune amplification, interleukin 1β and tumor necrosis factor are released by cells of the monocyte/macrophage lineage, with the potential to influence profoundly immune regulation systemically or within the central nervous system. Regulation of monocyte inflammatory gene expression may be relevant to the pathogenesis of MS. We investigated spontaneous secretion of interleukin 1 β, tumor necrosis factor a, and prostaglandin E2 with the use of monocytes that we isolated from patients with active (n=9) and stable (n=9) MS and from age-matched normal controls (n = 9). The patient groups with MS were matched for age, duration of MS, and disease severity. Patients with active disease were within weeks of the onset of a clinical exacerbation. Monocytes were isolated by density gradient centrifugation, followed by adherence to plastic tissue culture flasks, resulting in a highly purified adherent monocyte preparation. Monocytes from patients with active disease spontaneously secreted less tumor necrosis factor and less prostaglandin E2 compared with that in patients with stable MS, while interleukin 1β levels were below the level of assay sensitivity. Levels of interleukin 1 β and tumor necrosis factor increased to similar levels in response to lipopolysaccharide (0.1 mg/L), indicating that altered cell viability could not account for the observed differences. In response to lipopolysaccharide, prostaglandin E2 levels increased more significantly in patients with stable than active MS, suggesting differential sensitivity to stimuli of arachidonic acid metabolism. The results documented functional differences between monocytes that were isolated from patients with active compared with stable MS and suggested that peripheral inflammatory monokine secretion parallels MS disease activity.
Author Affiliations
From the Department of Neurology, Mellen Center for Multiple Sclerosis Treatment and Research (Drs Rudick and Ransohoff) and Departments of General Medical Sciences (Dr Rudick) and Molecular Biology (Dr Ransohoff), Cleveland (Ohio) Clinic Foundation.
Footnotes
Accepted for publication August 21, 1991.
Reprint requests to Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH 44195 (Dr Rudick).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Enzyme-Linked Immunospot Assays Provide a Sensitive Tool for Detection of Cytokine Secretion by Monocytes
Kouwenhoven et al.
CVI 2001;8:1248-1257.
ABSTRACT
| FULL TEXT
Cytokine-mediated Induction of Ceramide Production Is Redox-sensitive. IMPLICATIONS TO PROINFLAMMATORY CYTOKINE-MEDIATED APOPTOSIS IN DEMYELINATING DISEASES
Singh et al.
J. Biol. Chem. 1998;273:20354-20362.
ABSTRACT
| FULL TEXT
Mood Disorders and Dysfunction of the Hypothalamic-Pituitary-Adrenal Axis in Multiple Sclerosis: Association With Cerebral Inflammation
Fassbender et al.
Arch Neurol 1998;55:66-72.
ABSTRACT
| FULL TEXT
Inhibitors of tumor necrosis factor-{alpha}: Promising agents for the treatment of multiple sclerosis?
Hohlfeld
Mult Scler 1996;1:376-378.
ABSTRACT
An evaluation of tumor necrosis factor microsatellite alleles in genetic susceptibility to multiple sclerosis
Sandberg-Wollheim et al.
Mult Scler 1995;1:181-185.
ABSTRACT
|